HomeMIRA • NASDAQ
add
Mira Pharmaceuticals Inc
Previous close
$1.54
Day range
$1.52 - $1.59
Year range
$0.74 - $2.45
Market cap
66.58M USD
Avg Volume
273.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.32M | -36.73% |
Net income | -1.14M | 44.34% |
Net profit margin | — | — |
Earnings per share | -0.07 | 51.29% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.54M | 81.83% |
Total assets | 7.63M | 78.91% |
Total liabilities | 83.93K | -87.89% |
Total equity | 7.55M | — |
Shares outstanding | 41.88M | — |
Price to book | 8.11 | — |
Return on assets | -77.45% | — |
Return on capital | -81.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.14M | 44.34% |
Cash from operations | -1.10M | 40.45% |
Cash from investing | — | — |
Cash from financing | 3.01M | -4.90% |
Net change in cash | 1.91M | 44.69% |
Free cash flow | -997.18K | 27.88% |
About
Founded
2020
Headquarters
Website
Employees
3
